Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Gaudium IVF & Women Health IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Gaudium IVF Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹
3.12 and post-issue EPS of ₹
2.63 for FY25. The pre-issue P/E ratio is
25.32x,while the post-issue P/E ratio is
30.06x against the Industry P/E ratio is
26.49x The company's ROE for FY25 is
41.31% and RoNW is
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 3.12 |
| EPS Post IPO (Rs.) | 2.63 |
| Adjusted 12M EPS Post IPO (Rs.) | 3.44 |
| P/E Pre IPO | 25.32 |
| P/E Post IPO | 30.06 |
| Adjusted 12M P/E Post IPO | 22.99 |
| ROE | 41.31% |
| ROCE | 39.37% |
| P/BV | 10.48 |
| Debt/Equity | 0.41 |
| RoNW | 41.71% |
| EBITDA Margin | 40.48% |
| PAT Margin | 26.96% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
